Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

622 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure.
St John Sutton MG, Plappert T, Abraham WT, Smith AL, DeLurgio DB, Leon AR, Loh E, Kocovic DZ, Fisher WG, Ellestad M, Messenger J, Kruger K, Hilpisch KE, Hill MR; Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group. St John Sutton MG, et al. Among authors: abraham wt. Circulation. 2003 Apr 22;107(15):1985-90. doi: 10.1161/01.CIR.0000065226.24159.E9. Epub 2003 Mar 31. Circulation. 2003. PMID: 12668512 Clinical Trial.
Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE).
Sutton MG, Plappert T, Hilpisch KE, Abraham WT, Hayes DL, Chinchoy E. Sutton MG, et al. Among authors: abraham wt. Circulation. 2006 Jan 17;113(2):266-72. doi: 10.1161/CIRCULATIONAHA.104.520817. Epub 2006 Jan 9. Circulation. 2006. PMID: 16401777 Clinical Trial.
Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
Linde C, Gold M, Abraham WT, Daubert JC; REVERSE Study Group. Linde C, et al. Among authors: abraham wt. Am Heart J. 2006 Feb;151(2):288-94. doi: 10.1016/j.ahj.2005.03.002. Am Heart J. 2006. PMID: 16442890
Cardiac resynchronization therapy.
Abraham WT. Abraham WT. Prog Cardiovasc Dis. 2006 Jan-Feb;48(4):232-8. doi: 10.1016/j.pcad.2005.11.001. Prog Cardiovasc Dis. 2006. PMID: 16517245 Review.
Cardiac resynchronization treatment of heart failure.
Hasan A, Abraham WT. Hasan A, et al. Among authors: abraham wt. Annu Rev Med. 2007;58:63-74. doi: 10.1146/annurev.med.57.051804.122251. Annu Rev Med. 2007. PMID: 16987080 Review.
Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.
Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C; REVERSE (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) Study Group. Linde C, et al. Among authors: abraham wt. J Am Coll Cardiol. 2008 Dec 2;52(23):1834-1843. doi: 10.1016/j.jacc.2008.08.027. Epub 2008 Nov 7. J Am Coll Cardiol. 2008. PMID: 19038680 Free article. Clinical Trial.
622 results